[276 Pages Report] The global pharmaceutical packaging market size is estimated to be USD 99.9 billion in 2021 and is expected to reach USD 196.8 billion by 2026, at a CAGR of 14.5% from 2021 to 2026. This growth is attributed to the increased demand for pharmaceutical packaging in pharmerging economies such as Brazil, Russia, India, and China. The demand for technologically advanced solutions, such as self-administered drug delivery devices, is on the rise in developed countries such as the US, the UK, Japan, Germany, and others. Moreover, rising healthcare expenses, and growing consumer awareness regarding healthier lifestyle is driving the market for pharmaceutical packaging.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 impact on Global Pharmaceutical packaging Market
Covid-19 pandemic had adverse effects on the global healthcare industry. Impact of COVID-19 pandemic on the pharmaceutical sector included demand changes, regulation adjustments, R&D process modifications, supply chain restructuring, and the shift towards tele-consulting and tele-medicine. In addition, trends such as industry slow-down, approval delays, self-sufficiency in pharmaceutical production supply chain, modifying clinical trial methods, and variations in consumption of health & nutritional products could be some of the anticipated long-term impacts of COVID-19 pandemic on pharmaceutical sector at both global and local level.
Packaging activities were considered crucial during the COVID-19 pandemic. Pharmaceutical packaging companies gained from this and experienced stable revenue growth in 2020. Major pharmaceutical packaging companies had expanded their production to support the increased demand for pre-filled syringes, blister packs, vials, pouches, cartridges, bottles, and containers. This was mainly due to increased demand for Covid related vaccines and medications. In addition, pharmaceutical packaging for biologics, sterile packaging, smart packaging, patient focus packaging, cleanroom expansion, and others would drive the market in the long term.
The demand for drug delivery devices and innovative packaging is increasing with the growing use of biologics and non-traditional administration routes such as nasal, transdermal, rectal, and IV. These systems have changed the market dynamics and have become as important as the drug itself. Growing preference for unit dosage packaging is further fueling the growth of this segment. The growing prevalence of chronic diseases, growth in biologics market, and technological advancements are expected to further drive the market for drug delivery and related packaging systems.
Blister packaging is gaining popularity owing to its ease of use. It is used for packaging of drugs as unit-dose packaging system. This packaging requires fewer resources to manufacture, provides compact packaging, has greater shelf life, better product visibility, easy handling, and availability at lower cost compared to rigid bottles, bags, etc. The growing over-the-counter medicine sale and increased level of product safety from contaminants such as moisture and oxygen are also driving the growth of this type of packaging. This type of packaging is easier to use and can also be customized according to patient requirements.
According to a WHO report, nearly half of the global population is unable to afford required healthcare services. In 2017, around 800 million spent at least 10% of their household budget in health expenses which reduced their household income to near poverty, as per findings by Global Monitoring Report.
Poverty is a major barrier to accessing healthcare facilities in these emerging economies. Financial constraints, lack of information, outdated equipment, lack of proper staff, and awareness of proper healthcare practices are the major challenges that limit the access to healthcare services. These issues together restrain the growth of the pharmaceutical packaging market in emerging regions such as India, Brazil, South Africa, and others. However, better government policies and strict implementation of regulations will boost the market in the next five years.
Rise of advanced and diverse drug producing companies in developed economies such as the US, Japan, Canada, Germany, France, and the UK and growth in use of advanced packaging technologies such as patient specific dosages, eco-friendly packaging, and innovative counterfeiting techniques will drive the growth for primary packaging. Furthermore, India, Russia, Turkey, Mexico, Argentina, and China are expected to become some of the fastest growing markets owing to rapidly expanding pharmaceutical manufacturing capabilities and adoption of more stringent regulations intended at improving the quality and reliability of domestically produced drugs.
Counterfeit drugs are made with incorrect ingredients in improper quantities, which when consumed would result in dangerous effects such as allergic reactions or sometimes death. Anti-malarial and antibiotics are among the most commonly counterfeited medical products. Nearly half of the counterfeit drugs are reported in developing economies such as China, Vietnam, and the Philippines. These counterfeit products have negative effects on the human body, in terms of allergic reactions, vomiting, nausea, and others. Safeguarding against these counterfeit products is a major challenge for the sector.
Plastic offers freedom of design and cost-effective solution, making it a highly compatible solution for pharmaceutical packaging. The plastics & polymers segment dominates the overall pharmaceutical packaging market. HDPE is the most widely used material in the plastics & polymers segment. The market for this segment is driven by the increasing demand for plastic bottles, medical specialty bags, and other pharmaceutical packaging components made of plastic or polymer.
Prefilled syringes are prepacked single dose unit of drugs in which the needle has been fixed. Prefilled syringes provide advantages such as minimal drug wastage, increased product lifespan, enhanced protection, ease of use, reliable, sterility, self-medication features, and others. These packaging are convenient and ease the administration process to patients. These systems reduce patient exposure to toxic substance and decrease needle sticks.
Oral drug delivery is the most preferred administration route for any drug owing to its noninvasiveness, high patient compliance, convenience of handling, and non-requirement of any specific sterile conditions. Oral drug delivery mode is anticipated to be the largest category in the overall pharmaceutical packaging market. This large market size can be attributed to the convenience in usage, increased incidence of chronic diseases, improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, and heavy investments made by big pharmaceutical players for enhancing in-house capabilities to develop oral drug delivery technologies.
APAC is forecasted to be the fastest-growing region in the pharmaceutical packaging market in 2020. The recent trends toward improved healthcare systems and access to healthcare services in APAC could offer the pharmaceutical packaging providers new opportunities for growth in the region. The pharmerging market of the APAC region is expected to witness the fastest growth in the coming years due to increasing government initiatives, growing population, changing lifestyle, growing contract manufacturing activities, and the aging population. Increasing government initiatives in emerging pharmaceutical market, increase in contract manufacturing activities, rise in aging population, and increased spending on healthcare are driving the market in APAC. Japan, China, Australia, India, and South Korea are the major markets in this region. In addition, growing technological advancements in healthcare sector in countries such as China, Singapore, Malaysia, Thailand, and others, increasing urbanization, and changing lifestyle are also some of the driving factors for the market growth in pharmaceutical packaging industry.
To know about the assumptions considered for the study, download the pdf brochure
The key players in the pharmaceutical packaging market include Berry Global (US), Catalent (US), Schott AG (Germany), West Pharmaceutical Services, Inc. (US), WestRock (US), Aptar Group (US), Gerresheimer AG (Germany), and Amcor (Switzerland). The pharmaceutical packaging market report analyzes the key growth strategies, such as new product launches, investments & expansions, joint ventures, agreements, partnerships, and mergers & acquisitions adopted by the leading market players between 2018 and 2021.
Market Size Value in 2021
USD 99.9 billion
Revenue Forecast in 2026
USD 196.8 billion
Years considered for the study
Base year considered
Volume (Kiloton) and Value (USD)
Raw Material, Types, Drug Delivery Modes, and Region
North America, APAC, Europe, Middle East & Africa, and South America
Schott AG (Germany), Amcor (Switzerland), Aptar Group (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent (US), and WestRock (US)
This research report categorizes the pharmaceutical packaging market based on raw material, types, drug delivery modes, and region.
The pharmaceutical packaging market has been further analyzed based on key countries in each of these regions.
What is the current size of the global pharmaceutical packaging market?
Global pharmaceutical packaging market size is estimated to reach USD 196.8 billion by 2026 from USD 99.9 billion in 2021, at a CAGR of 14.5% during the forecast period.
Are there any regulations for pharmaceutical packaging?
Several countries in Europe and North America have introduced regulations for this market. For e.g., in the European Union, European Medicines Agency and European Commission oversee the proper packaging for active substances or medicinal products. The US Food & Drug Administration (US FDA) is the authority which regulates and provides guidelines on packaging, labelling, storage, and transport of medical products in the US.
Who are the winners in the global pharmaceutical packaging market?
Companies such as Schott AG, Amcor, Aptar Group, West Pharmaceutical Services, Berry Global, Gerresheimer AG, Catalent, Nolato, SGD Pharma, Origin Pharma, and WestRock under the winner’s category. They have the potential to broaden their product portfolio and compete with other key market players. Such advantages give these companies an edge over other companies.
What is the COVID-19 impact on pharmaceutical packaging manufacturers?
Packaging activities were considered essential during the pandemic. Pharmaceutical packaging companies benefitted from this and experienced stable revenue growth in 2020. Pharmaceutical packaging companies had increased their productivity to support the increased demand for blister packs, vials, pre-filled syringes, containers, bottles, cartridges, and pouches. This was mainly due to increased demand for Covid related medications, and vaccines.
What are some of the drivers in the market?
The increasing requirement of pharmaceutical packaging in emerging economies and demand for new and advanced drug delivery systems drive the market. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 SCOPE OF THE STUDY
1.5 PACKAGE SIZE
1.7 SUMMARY OF CHANGES
1.8 INCLUSIONS & EXCLUSIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
188.8.131.52 Key data from secondary sources
2.1.2 PRIMARY DATA
184.108.40.206 Key data from primary sources
220.127.116.11 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 MARKET SIZE ESTIMATION
2.5 FORECAST ESTIMATION
2.6 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
4.2 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
4.3 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
4.4 PHARMACEUTICAL PACKAGING MARKET GROWTH RATE, BY COUNTRY
5 MARKET OVERVIEW
5.2 MARKET SEGMENTATIONS
5.3 MARKET DYNAMICS
6 INDUSTRY TRENDS
6.2 VALUE CHAIN ANALYSIS
6.2.1 RAW MATERIAL
6.2.2 EQUIPMENT MANUFACTURERS
6.3 PORTER’S FIVE FORCES ANALYSIS
6.3.1 THREAT OF SUBSTITUTES
6.3.2 BARGAINING POWER OF BUYERS
6.3.3 THREAT OF NEW ENTRANTS
6.3.4 BARGAINING POWER OF SUPPLIERS
6.3.5 INTENSITY OF COMPETITIVE RIVALRY
6.4 PATENT ANALYSIS
6.5 PRICING ANALYSIS
6.5.1 AVERAGE SELLING PRICES OF KEY PLAYERS
6.6 ECOSYSTEM/ MARKET MAPPING
6.7 TECHNOLOGY ANALYSIS
6.8 KEY CONFERENCES AND EVENTS
6.9 TARRIF AND REGULATORY LANDSCAPE
6.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.10 KEY STAKEHOLDERS AND BUYING CRITERIA
6.11 CASE STUDIES
7 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
7.3 PAPER & PAPERBOARD
8 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
8.2 PLASTIC BOTTLES
8.3 BLISTER PACKS
8.4 LABELS & ACCESSORIES
8.5 CAPS & CLOSURES
8.6 MEDICAL SPECIALTY BAGS
8.7 PRE-FILLED SYRINGES
8.8 TEMPERATURE CONTROLLED PACKAGING
8.9 POUCHES & STRIP PACKS
8.12 PRE-FILLED INHALERS
8.13 MEDICATION TUBES
8.14 JARS & CANISTERS
9 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
9.2 ORAL DRUG DELIVERY PACKAGING
9.3 PULMONARY DRUG DELIVERY PACKAGING
9.4 TRANSDERMAL DRUG DELIVERY PACKAGING
9.5 INJECTABLE PACKAGING
9.6 TOPICAL DRUG DELIVERY PACKAGING
9.7 NASAL DRUG DELIVERY PACKAGING
9.8 OCULAR DRUG DELIVERY PACKAGING
9.9 IV DRUG DELIVERY PACKAGING
9.10 OTHER DRUG DELIVERY PACKAGING
10 PHARMACEUTICAL PACKAGING MARKET, BY REGION
10.2.4 SOUTH KOREA
10.2.6 REST OF APAC
10.3 NORTH AMERICA
10.4.6 REST OF EUROPE
10.5 MIDDLE-EAST & AFRICA
10.5.1 SAUDI ARABIA
10.5.2 SOUTH AFRICA
10.5.4 REST OF MEA
10.6 SOUTH AMERICA
10.6.3 REST OF SOUTH AMERICA
11 COMPETITIVE LANDSCAPES
11.1.1 KEY PLAYER STRATEGIES/ RIGHT TO WIN
11.1.2 OVERVIEW OF STRATEGIES DEPLOYED
11.2 MARKET EVALUATION FRAMEWORK
11.3 COMPANY REVENUE ANALYSIS
11.4 MARKET SHARE/RANKING OF KEY PLAYERS
11.5 COMPETITIVE SITUATION AND TRENDS
11.5.1 NEW LAUNCHES
11.5.3 JVS/ TECHNLOLOGIAL COLLABORATIONS
12 COMPANY PROFILES*
((Business Overview, Financials**, Products Offered, Scorecard of Product Offering, Scorecard of Business Strategy, and Recent Developments)
12.1 BERRY GLOBAL INC.
12.1.1 Business overview
12.1.2 Products offered
12.1.3 Recent Developments
12.1.4 MnM view
18.104.22.168 Key strengths/right to win
22.214.171.124 Strategic choices made
126.96.36.199 Weaknesses and competitive threats
12.2 GERRESHEIMER AG
12.3 AMCOR PLC
12.4 SCHOTT AG
12.5 APTARGROUP, INC.
12.6 BECTON, DICKINSON AND COMPANY
12.7 CATALENT, INC.
12.8 NIPRO CORPORATION
12.9 WEST PHARMACEUTICAL SERVICES, INC.
12.11 OTHER COMPANIES
The study involved four major activities in estimating the current market size for pharmaceutical packaging. The exhaustive secondary research was conducted to collect information on the market, peer market, and child market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, the market breakdown and data triangulation methodologies were used to estimate the market size of segments and sub-segments.
In the secondary research process, various secondary sources such as Bloomberg, World Bank, Statista, European Medical Agency, Packaging Industry Associations, Trademap, Zauba, were referred to for identifying and collecting information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, regulations form agencies such as the Food & Drug Administration, World Health organization (WHO), The European Federation of Pharmaceutical Industries and Associations (EFPIA), Pharmaceuticals Export Promotion Council of India, regulatory bodies, and databases.
The pharmaceutical packaging market comprises several stakeholders such as raw material suppliers, distributors of pharmaceutical packaging, end-users, and regulatory organizations in the supply chain. The demand side of this market consists of pharmaceutical drug manufacturers, medical drug filling contractors, hospitals, labs, research institutes, and other healthcare institutions. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.
Following is the breakdown of primary respondents
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the pharmaceutical packaging market. These methods were also used extensively to estimate the size of various sub-segments in the market. The research methodology used to estimate the market size includes the following:
After arriving at the overall market size—using the market size estimation process explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply of pharmaceutical packaging and their applications.
Notes: 1. Micro markets are defined as sub segments of the pharmaceutical packaging market included in the report.
2. Core competencies of the companies are covered in terms of their key developments and strategies adopted to sustain their position in the market.
With the given market data, MarketsandMarkets offers customizations according to the specific requirements of companies. The following customization options are available for the report: